CAMPAGNA, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 1.746
EU - Europa 1.151
AS - Asia 626
SA - Sud America 81
AF - Africa 31
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.639
Nazione #
US - Stati Uniti d'America 1.734
IT - Italia 387
SG - Singapore 229
HK - Hong Kong 176
CN - Cina 154
RU - Federazione Russa 154
IE - Irlanda 137
SE - Svezia 99
BR - Brasile 77
UA - Ucraina 75
DE - Germania 70
FR - Francia 59
FI - Finlandia 34
AT - Austria 33
GB - Regno Unito 32
CI - Costa d'Avorio 24
DK - Danimarca 20
IN - India 19
KR - Corea 18
RO - Romania 12
TR - Turchia 10
CA - Canada 9
BE - Belgio 7
JP - Giappone 7
NL - Olanda 6
PL - Polonia 6
CZ - Repubblica Ceca 4
HR - Croazia 4
SM - San Marino 4
AU - Australia 3
LT - Lituania 3
MA - Marocco 3
BD - Bangladesh 2
ID - Indonesia 2
MX - Messico 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
BG - Bulgaria 1
BJ - Benin 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
ES - Italia 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
PK - Pakistan 1
PY - Paraguay 1
TN - Tunisia 1
VE - Venezuela 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 3.639
Città #
Chandler 275
Hong Kong 175
Des Moines 144
Singapore 144
Dublin 137
Ashburn 135
Boardman 132
Fairfield 100
Jacksonville 84
Ancona 65
Seattle 57
Turin 49
Wilmington 49
New York 46
Houston 40
The Dalles 39
Moscow 38
Woodbridge 37
Lawrence 35
Princeton 35
Cambridge 34
Centro 32
Ann Arbor 28
Tolentino 25
Abidjan 24
San Mateo 23
Vienna 23
Washington 22
Shanghai 20
Helsinki 19
Milan 19
San Diego 19
Aversa 16
Nuremberg 16
Rome 16
Redmond 15
Wuhan 13
Brasov 12
London 12
Los Angeles 12
Beijing 10
Guangzhou 10
Marche 10
Pune 9
Rieti 9
Boydton 7
Brussels 7
Hangzhou 7
Turku 7
Cagliari 6
Dallas 6
Maringá 6
Munich 6
Pittsburgh 6
Wuxi 6
Curitiba 5
Istanbul 5
Jiaxing 5
Jinhua 5
Perugia 5
Pesaro 5
Belo Horizonte 4
Borgo Maggiore 4
Chennai 4
Civitanova Marche 4
Falconara Marittima 4
Iesi 4
Naples 4
Pavia 4
Radomsko 4
San Francisco 4
Toronto 4
Zagreb 4
Zibo 4
Andover 3
Columbus 3
Manassas 3
Manchester 3
Marigliano 3
Montelupone 3
Namhyang-dong 3
Olomouc 3
Quanzhou 3
Redwood City 3
Shenzhen 3
Stockholm 3
Yiwu 3
Ascoli Piceno 2
Bangkok 2
Bhubaneswar 2
Bielefeld 2
Boston 2
Caserta 2
Chiaravalle 2
Chicago 2
Chiswick 2
Corropoli 2
Delhi 2
Denver 2
Divinópolis 2
Totale 2.475
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 219
Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma 126
Nicotinamide N-Methyltransferase Inhibition in Endothelium: Effect on Cell Viability and Respiration 125
Cancer stem cell enrichment is associated with enhancement of nicotinamide N-methyltransferase expression 118
Clinical performance and utility of a NNMT-based urine test for bladder cancer 116
Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 98
Bladder Cancer Chemosensitivity is Affected by Paraoxonase-2 Expression 93
Molecular analysis of endometrial inflammation in preterm birth 88
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 86
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 82
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 79
Overexpression of Nicotinamide N-Methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation 74
Cancer stem cells from human tumor cell lines: molecular and phenotypic features 71
Macrocyclic peptides as allosteric inhibitors of nicotinamide N-methyltransferase (NNMT) 71
Molecular and phenotypic characterization of cancer stem cells from human tumor cell lines 68
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 67
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 67
Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside 67
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 66
Bardoxolone Methyl Displays Detrimental Effects on Endothelial Bioenergetics, Suppresses Endothelial ET-1 Release, and Increases Endothelial Permeability in Human Microvascular Endothelium 66
Nicotinamide N-methyltransferase gene silencing in endothelial cell lines: molecular and phenotypic characterization 65
Actin-spectrin scaffold supports open fenestrae in liver sinusoidal endothelial cells 65
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 64
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 64
Esterase-Sensitive Prodrugs of a Potent Bisubstrate Inhibitor of Nicotinamide N-Methyltransferase (NNMT) Display Cellular Activity 63
PON2 silencing to evaluate the effectiveness of Cisplatin treatment in OSCC cells by FTIRM analyses 63
Nicotinamide N-methyltransferase in endothelium protects against oxidant stress-induced endothelial injury 61
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 60
Potent Inhibition of Nicotinamide N-Methyltransferase by Alkene-Linked Bisubstrate Mimics Bearing Electron Deficient Aromatics 60
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 60
C. spinosa L. subsp. rupestris Phytochemical Profile and Effect on Oxidative Stress in Normal and Cancer Cells 57
The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update 57
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 57
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 56
Characterization of cancer stem cells from larynx and bladder carcinoma cell lines 56
Nicotinamide N-methyltransferase inhibition in endothelial cell lines: effect on the cellular phenotype, cell viability and bioenergetic balance 53
Nicotinamide N-Methyltransferase as Promising Tool for Management of Gastrointestinal Neoplasms 52
Nicotinamide N-methyltransferase inhibition in endothelium: effect on the cellular phenotype, viability and bio-energetics 52
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 49
FTIRM analyses as a tool to explore cisplatin sensitivity of oral squamous cell carcinoma cell lines after PON2 knockdown 47
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 46
Effect of nicotinamide N-methyltransferase gene silencing on endothelial bioenergetics. 45
Nicotinamide N-Methyltransferase in Head and Neck Tumors: A Comprehensive Review 42
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 41
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 39
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 39
Curcumin and its Analogues in Oral Squamous Cell Carcinoma: State-of-the-art and Therapeutic Potential 39
NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health 38
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 38
Paraoxonase-2 expression in oral squamous cell carcinoma 38
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 34
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 34
In Vitro Study of the Proliferation of MG63 Cells Cultured on Five Different Titanium Surfaces 33
The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update 31
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 31
Paraoxonase-2 shRNA-mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines 31
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. 31
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 30
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 30
Nicotinamide N-methyltransferase: a key enzyme of pyridine metabolism and a target for human osteosarcoma treatment 30
Exploring the role of paraoxonase-2 in human clear cell renal cell carcinoma: in vitro effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 29
Deepening Cisplatin sensitivity on Oral Squamous cell Carcinoma cell lines after PON2 knockdown: A FTIRM investigation 27
Role of nicotinamide N-methyltransferase in human osteosarcoma: in vitro effect of shRNA-mediated gene silencing on tumorigenicity 26
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges 24
The Multifaceted Role of the Polyphenol Curcumin: A Focus on Type 2 Diabetes Mellitus 22
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 21
Nrf2 Signaling in Renal Cell Carcinoma: A Potential Candidate for the Development of Novel Therapeutic Strategies 14
Novel Ti6Al4V Surface Treatment for Subperiosteal Dental Implants: Evaluation of Osteoblast-like Cell Proliferation and Osteogenic Response 12
Totale 3.903
Categoria #
all - tutte 25.414
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.414


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 0 0 0 0 0 0 20 22
2020/2021360 15 20 29 1 21 70 79 14 23 27 43 18
2021/2022359 17 59 40 4 0 19 12 59 9 14 45 81
2022/2023921 55 87 63 81 54 214 13 58 182 7 73 34
2023/2024771 98 16 57 66 105 113 10 18 15 95 36 142
2024/20251.182 155 74 78 38 72 32 134 69 249 160 121 0
Totale 3.903